Development of Nonalcoholic Steatohepatitis in Insulin-Resistant Liver-Specific S503A Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Mutant Mice

Gastroenterology

Volumn 135, Issue 6, 2008, Pages 2084-2095

  Lee, Sang Jun ^a   Heinrich, Garrett ^a   Fedorova, Larisa ^b   Al Share, Qusai Y ^a   Ledford, Kelly J ^a   Fernstrom, Mats A ^a   McInerney, Marcia F ^c   Erickson, Sandra K ^d   Gatto Weis, Cara ^a   Najjar, Sonia M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF TOLEDO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROCOLLAGENASE; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; HISTOPATHOLOGY; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIVER NECROSIS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WILD TYPE;

EID: 57249094022     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.08.007     Document Type: Article

References (53)

1. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
2. Hui J.M., Kench J.G., Chitturi S., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 (2003) 420-427
3. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
4. Yoon J.C., Puigserver P., Chen G., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 (2001) 131-138
5. Echtay K.S., Murphy M.P., Smith R.A., et al. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277 (2002) 47129-47135
6. Chavin K.D., Yang S., Lin H.Z., et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274 (1999) 5692-5700
7. Arkan M.C., Hevener A.L., Greten F.R., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11 (2005) 191-198
8. Dela Pena A., Leclercq I., Field J., et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129 (2005) 1663-1674
9. McClain C.J., Mokshagundam S.P., Barve S.S., et al. Mechanisms of non-alcoholic steatohepatitis. Alcohol 34 (2004) 67-79
10. Marchesini G., and Marzocchi R. Metabolic syndrome and NASH. Clin Liver Dis 11 (2007) 105-117
11. Abdelmalek M.F., and Diehl A.M. Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91 (2007) 1125-1149 ix
12. Green R.M. NASH-hepatic metabolism and not simply the metabolic syndrome. Hepatology 38 (2003) 14-17
13. Otogawa K., Kinoshita K., Fujii H., et al. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am J Pathol 170 (2007) 967-980
14. Leclercq I.A., Farrell G.C., Schriemer R., et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37 (2002) 206-213
15. Kurlawalla-Martinez C., Stiles B., Wang Y., et al. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol 25 (2005) 2498-2510
16. Nakayama H., Otabe S., Ueno T., et al. Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis. Metabolism 56 (2007) 470-475
17. Poy M.N., Yang Y., Rezaei K., et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 30 (2002) 270-276
18. Gray-Owen S.D., and Blumberg R.S. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 6 (2006) 433-446
19. Nagaishi T., Pao L., Lin S.H., et al. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25 (2006) 769-781
20. Li Z., Soloski M.J., and Diehl A.M. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42 (2005) 880-885
21. Erickson S.K., Lear S.R., Dean S., et al. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J Lipid Res 44 (2003) 1001-1009
22. Bondini S., Kleiner D.E., Goodman Z.D., et al. Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis 11 (2007) 17-23
23. Kellogg A.P., Wiggin T.D., Larkin D.D., et al. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 56 (2007) 2997-3005
24. Najjar S.M., Yang Y., Fernstrom M.A., et al. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2 (2005) 43-53
25. Dai T., Abou-Rjaily G.A., Al-Share' Q.Y., et al. Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. J Biol Chem 279 (2004) 45155-45161
26. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 (2002) 1125-1131
27. Cai D., Yuan M., Frantz D.F., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11 (2005) 183-190
28. Manicassamy S., Gupta S., Huang Z., et al. Protein kinase C-theta-mediated signals enhance CD4+T cell survival by up-regulating Bcl-xL. J Immunol 176 (2006) 6709-6716
29. Patsouris D., Reddy J.K., Muller M., et al. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147 (2006) 1508-1516
30. Robertson G., Leclercq I., and Farrell G.C. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1135-G1139
31. Saraiva R.M., Minhas K.M., Zheng M., et al. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice. Nitric Oxide 16 (2007) 331-338
32. Alloatti G., Penna C., De Martino A., et al. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. Cardiovasc Res 41 (1999) 611-619
33. Simbulan-Rosenthal C.M., Rosenthal D.S., Iyer S., et al. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 273 (1998) 13703-13712
34. Charlton M., Sreekumar R., Rasmussen D., et al. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 35 (2002) 898-904
35. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110 (2002) 905-911
36. Soccio R.E., and Breslow J.L. Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol 24 (2004) 1150-1160
37. Mari M., Caballero F., Colell A., et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4 (2006) 185-198
38. Shen W.J., Patel S., Natu V., et al. Interaction of hormone-sensitive lipase with steroidogenic acute regulatory protein: facilitation of cholesterol transfer in adrenal. J Biol Chem 278 (2003) 43870-43876
39. Crespo J., Cayon A., Fernandez-Gil P., et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34 (2001) 1158-1163
40. Bigorgne A.E., Bouchet-Delbos L., Naveau S., et al. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of fatty liver inflammation in obese mice. Gastroenterology 134 (2008) 1459-1469
41. Enriquez A., Leclercq I., Farrell G.C., et al. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun 255 (1999) 300-306
42. Emery M.G., Fisher J.M., Chien J.Y., et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38 (2003) 428-435
43. Lieber C.S. CYP2E1: from ASH to NASH. Hepatol Res 28 (2004) 1-11
44. Schulze-Osthoff K., Beyaert R., Vandevoorde V., et al. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12 (1993) 3095-3104
45. Shimizu S., Eguchi Y., Kamiike W., et al. Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes. Am J Physiol 271 (1996) G949-G958
46. Carter-Kent C., Zein N.N., and Feldstein A.E. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 103 (2008) 1036-1042
47. Kremer M., Hines I.N., Milton R.J., et al. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 44 (2006) 216-227
48. Tiegs G. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 45 (2007) 63-70
49. Biddinger S.B., Hernandez-Ono A., Rask-Madsen C., et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 7 (2008) 125-134
50. Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30 (1999) 1356-1362
51. Chalasani N., Crabb D.W., Cummings O.W., et al. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?. Am J Gastroenterol 98 (2003) 2771-2776
52. Manco M., Marcellini M., Giannone G., et al. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 127 (2007) 954-960
53. Ong J.P., Elariny H., Collantes R., et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 15 (2005) 310-315